Publications by authors named "Susan Evans-Axelsson"

16Publications

Targeted alpha therapy in a systemic mouse model of prostate cancer - a feasibility study.

Theranostics 2020 3;10(6):2612-2620. Epub 2020 Feb 3.

Ahmanson Translational Theranostic Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles (UCLA), CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/thno.42228DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052903PMC
February 2020

Preserving Preclinical PET Quality During Intratherapeutic Imaging in Radionuclide Therapy with Rose Metal Shielding Reducing Photon Flux.

J Nucl Med 2019 05 2;60(5):710-715. Epub 2018 Nov 2.

Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.

View Article

Download full-text PDF

Source
http://jnm.snmjournals.org/lookup/doi/10.2967/jnumed.118.217
Publisher Site
http://dx.doi.org/10.2967/jnumed.118.217117DOI Listing
May 2019

Microscale radiosynthesis, preclinical imaging and dosimetry study of [F]AMBF-TATE: A potential PET tracer for clinical imaging of somatostatin receptors.

Nucl Med Biol 2018 06 20;61:36-44. Epub 2018 Apr 20.

Physics in Biology and Medicine Interdepartmental Graduate Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA; Crump Institute for Molecular Imaging, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA; Department of Molecular & Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center (JCCC), UCLA, Los Angeles, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09698051183007
Publisher Site
http://dx.doi.org/10.1016/j.nucmedbio.2018.04.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015542PMC
June 2018

Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model.

PLoS One 2017 8;12(9):e0184418. Epub 2017 Sep 8.

Department of Translational Medicine, Division of Cell and Experimental Pathology, Lund University, Clinical Research Centre, Skåne University Hospital Malmö, Malmö, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0184418PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590932PMC
October 2017

Radioimmunotherapy for Prostate Cancer--Current Status and Future Possibilities.

Semin Nucl Med 2016 Mar;46(2):165-79

Department of Clinical Sciences, Lund, Division of Medical Radiation Physics, Lund University, Lund, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semnuclmed.2015.10.005DOI Listing
March 2016

The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.

Eur Urol 2016 Mar 2;69(3):400-4. Epub 2015 Jul 2.

Department of Translational Medicine, Division of Urological Cancers, Skåne University Hospital Malmö, Lund University, Sweden. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838150051
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2015.06.016DOI Listing
March 2016

Radiolabeled antibodies in prostate cancer: a case study showing the effect of host immunity on antibody bio-distribution.

Nucl Med Biol 2015 Apr 23;42(4):375-80. Epub 2014 Dec 23.

Department of Surgery (Urology), Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Clinical Sciences, Division of Urological Research, Lund University, Malmö, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nucmedbio.2014.12.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472383PMC
April 2015

Preclinical evaluation of (111)In-DTPA-INCA-X anti-Ku70/Ku80 monoclonal antibody in prostate cancer.

Am J Nucl Med Mol Imaging 2014 7;4(4):311-23. Epub 2014 Jun 7.

Division of Urological Cancers, Department of Clinical Sciences Malmö, Lund University Sweden.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074497PMC
July 2014